What is he best known for?
The fields of study he is best known for:
Steven A. Stacker mostly deals with Vascular Endothelial Growth Factor D, Lymphangiogenesis, Lymphatic system, Vascular endothelial growth factor C and Cell biology.
Vascular Endothelial Growth Factor D is closely attributed to Endothelium in his study.
His work is dedicated to discovering how Lymphangiogenesis, Immunology are connected with LYN and other disciplines.
Steven A. Stacker interconnects Cancer, Metastasis and Lymphatic vessel in the investigation of issues within Lymphatic system.
Steven A. Stacker combines subjects such as Vascular endothelial growth factor B, Angiogenesis and Lymph sacs with his study of Vascular endothelial growth factor C.
His studies in Cell biology integrate themes in fields like Receptor, Internal medicine and Endocrinology.
His most cited work include:
- Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) (1125 citations)
- VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. (1068 citations)
- ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). (785 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Lymphangiogenesis, Cell biology, Angiogenesis, Lymphatic system and Vascular endothelial growth factor C.
His Lymphangiogenesis study combines topics from a wide range of disciplines, such as Immunology, Cancer research and Lymphatic Endothelium.
Cell biology is frequently linked to Endothelial stem cell in his study.
Steven A. Stacker has included themes like Molecular biology, Vascular endothelial growth inhibitor, Cell type and Vascular permeability in his Angiogenesis study.
His Lymphatic system study is concerned with the larger field of Pathology.
He usually deals with Vascular endothelial growth factor C and limits it to topics linked to Vascular Endothelial Growth Factor D and Endothelium and Therapeutic angiogenesis.
He most often published in these fields:
- Lymphangiogenesis (58.17%)
- Cell biology (51.71%)
- Angiogenesis (47.15%)
What were the highlights of his more recent work (between 2013-2021)?
- Lymphangiogenesis (58.17%)
- Cell biology (51.71%)
- Angiogenesis (47.15%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Lymphangiogenesis, Cell biology, Angiogenesis, Cancer research and Lymphatic system.
His Lymphangiogenesis study combines topics in areas such as Vascular endothelial growth factor C, Immunology and Lymphatic Endothelium.
His studies deal with areas such as Vascular Endothelial Growth Factor D and Zebrafish as well as Vascular endothelial growth factor C.
His work in the fields of Receptor tyrosine kinase, Wnt signaling pathway and WNT5A overlaps with other areas such as IQGAP2.
The various areas that he examines in his Angiogenesis study include Vascular endothelial growth factor A, VEGF signaling, Endothelium and Cancer biomarkers.
His Lymphatic system research incorporates elements of Cardiology, Inflammation, Internal medicine, Immune system and Lymphatic vessel.
Between 2013 and 2021, his most popular works were:
- Lymphangiogenesis and lymphatic vessel remodelling in cancer (378 citations)
- Consensus guidelines for the use and interpretation of angiogenesis assays (194 citations)
- Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination (128 citations)
In his most recent research, the most cited papers focused on:
His primary areas of study are Lymphangiogenesis, Vascular endothelial growth factor C, Cancer research, Immunology and Angiogenesis.
Lymphangiogenesis and Lymphatic system are frequently intertwined in his study.
The concepts of his Vascular endothelial growth factor C study are interwoven with issues in Vascular Endothelial Growth Factor D and Zebrafish.
His Vascular Endothelial Growth Factor D study is concerned with the field of Vascular endothelial growth factor as a whole.
His work focuses on many connections between Zebrafish and other disciplines, such as Cell biology, that overlap with his field of interest in Genetics.
Steven A. Stacker works mostly in the field of Cancer research, limiting it down to concerns involving Metastasis and, occasionally, Tumor hypoxia, Neoadjuvant therapy and Soft tissue sarcoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
